Growth Hormone and DHEA for IVF in Women with Low Ovarian Reserve
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests whether adding growth hormone and DHEA to your IVF medications can help women with low ovarian reserve get more eggs and improve pregnancy chances. It may be an option if you are over 40, have had few eggs before, or have low egg count markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have at least two of these: being over 40 (or having a reason for low egg response), getting 3 or fewer eggs in a past IVF cycle, or having low ovarian reserve (low AFC or AMH).
- You do not have any hormone or metabolic condition such as high prolactin, diabetes, or thyroid problems.
- You do not have any pelvic issues like blocked fallopian tubes or an abnormal uterus shape.
- There is no male infertility factor (like very low sperm count or no sperm).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a different type of fertility medication to help women who had fewer than 9 eggs retrieved in a previous IVF cycle. It's designed for women between 18 and 40 with a specific hormone profile, and aims to improve egg collection results.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This trial tests whether doing two shorter rounds of hormone stimulation in one menstrual cycle (dual ovarian stimulation) leads to more live births than the usual two separate stimulation cycles for women who have a low egg reserve. The goal is to find a better way to help women who have had limited success with IVF.
This trial tests whether adding a hormone (r-hLH) to standard ovarian stimulation medicine helps women aged 35 to 40 produce more eggs during IVF. It may be a good option if you have lower ovarian reserve and are starting your first or second IVF cycle.
This trial compares two starting doses of follicle-stimulating hormone (FSH) during in vitro fertilization (IVF) to see which works better. FSH helps your ovaries produce eggs, and the study aims to find the best dose for women with good fertility prospects.
This study tests whether a medication called etanercept, which reduces inflammation, can improve the chances of having a baby for women with low ovarian reserve who are doing IVF. It may help by making the womb more receptive to embryos.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.